Visium Asset Management
View Older Stories View More Recent Stories
-
Form SC 13G/A ALBANY MOLECULAR RESEARC Filed by: Visium Asset Management, LP
-
Form SC 13G/A Vericel Corp Filed by: Visium Asset Management, LP
-
Form SC 13G/A CONMED CORP Filed by: Visium Asset Management, LP
-
Form SC 13G/A BIO BLAST PHARMA LTD. Filed by: Visium Asset Management, LP
-
Form SC 13G/A APPLIED GENETIC TECHNOLO Filed by: Visium Asset Management, LP
-
Form SC 13G/A Sientra, Inc. Filed by: Visium Asset Management, LP
-
Form SC 13G/A AQUINOX PHARMACEUTICALS, Filed by: Visium Asset Management, LP
-
Form SC 13G/A Axovant Sciences Ltd. Filed by: Visium Asset Management, LP
-
Form 13F-HR Visium Asset Management, For: Dec 31
-
Form SC 13G Sage Therapeutics, Inc. Filed by: Visium Asset Management, LP
-
Form SC 13G LA JOLLA PHARMACEUTICAL Filed by: Visium Asset Management, LP
-
U.S. hedge funds boast lower losses as markets tumble further
-
Caution, teamwork trumped bravado for some hedge funds in 2015
-
Ackman's Pershing Square ends 2015 with 20.5 pct drop
-
Visium Asset Management, LP Raises Stake in Zeltiq Aesthetics (ZLTQ) to 5.6%
-
Form SC 13G Zeltiq Aesthetics Inc Filed by: Visium Asset Management, LP
-
Form 13F-HR Visium Asset Management, For: Sep 30
-
RedHill Biopharma Reports Results for the Third Quarter of 2015
-
2nd Annual IP Dealmakers Forum, Dec 7-8 in NYC, to Bridge Investment and Intellectual Property Communities
-
Form SC 13G/A SPECTRANETICS CORP Filed by: Visium Asset Management, LP
-
Form SC 13G AQUINOX PHARMACEUTICALS, Filed by: Visium Asset Management, LP
-
Ackman's Pershing Square hedge fund drops 9.2 percent in August
-
Hedge fund Visium Balanced rose in August, up 11.2 percent YTD
-
Form SC 13G Ascendis Pharma A/S Filed by: Visium Asset Management, LP
-
Form 13F-HR Visium Asset Management, For: Jun 30
-
Form SC 13G Pacira Pharmaceuticals, Filed by: Visium Asset Management, LP
-
RedHill Biopharma Reports Results for the Second Quarter of 2015
-
RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares
-
Form SC 13G Axovant Sciences Ltd. Filed by: Visium Asset Management, LP
-
Neuberger Berman Absolute Return Multi-Manager Fund Hits 3 Years With Category Outperformance
-
Form 13F-HR Visium Asset Management, For: Mar 31
-
Visium Asset Management Launches Long/Short U.S. Equities UCITS FundĀ
-
Form SC 13G/A MOMENTA PHARMACEUTICALS Filed by: Visium Asset Management, LP
-
Neuberger Berman Absolute Return Multi-Manager Fund Wins Institutional Investor "Innovation In Alternative Mutual Funds" Award
-
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: Visium Asset Management, LP
-
Form SC 13G Esperion Therapeutics, Filed by: Visium Asset Management, LP
-
Form SC 13G/A WRIGHT MEDICAL GROUP Filed by: Visium Asset Management, LP
-
Form 13F-HR Visium Asset Management, For: Dec 31
-
Form SC 13G/A NephroGenex, Inc. Filed by: Visium Asset Management, LP
-
Form SC 13G/A Vericel Corp Filed by: Visium Asset Management, LP
-
Form SC 13G/A QLT INC Filed by: Visium Asset Management, LP
-
Form SC 13G/A WRIGHT MEDICAL GROUP Filed by: Visium Asset Management, LP
-
Form SC 13G/A Revance Therapeutics, Filed by: Visium Asset Management, LP
-
Form SC 13G/A INTERCEPT PHARMACEUTICAL Filed by: Visium Asset Management, LP
-
Form SC 13G/A ZOGENIX, INC. Filed by: Visium Asset Management, LP
-
Form SC 13G/A ASSEMBLY BIOSCIENCES, Filed by: Visium Asset Management, LP
-
Form SC 13G/A REPROS THERAPEUTICS INC. Filed by: Visium Asset Management, LP
-
Form SC 13G/A MOMENTA PHARMACEUTICALS Filed by: Visium Asset Management, LP
-
Form SC 13G/A PAIN THERAPEUTICS INC Filed by: Visium Asset Management, LP
-
Form SC 13G/A BIO BLAST PHARMA LTD. Filed by: Visium Asset Management, LP

